Edward Feliksovich Agletdinov
Edward Feliksovich Agletdinov has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia V. Baraboshkina
«Vector-Best» RIDT JSC, 630117 Novosibirsk, Russia
3 shared publications - Davyd A. Yakhontov
Novosibirsk State Medical University
3 shared publications - Elena I. Krasnova
Novosibirsk State Medical University, Novosibirsk, Russia
3 shared publications - Ksenia A. Cheremisina
«Vector-Best» RIDT JSC, 630117 Novosibirsk, Russia
3 shared publications - V. V. Provorova
Novosibirsk State Medical University, Novosibirsk, Russia
3 shared publications - Ya.S. Ulyanova
City Infectious Diseases Clinical Hospital No. 1, Novosibirsk, Russia, Novosibirsk State Medical University, Novosibirsk, Russia
3 shared publications
Latest Publications
- Open Access
- 30 August 2026
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 46 (4) , 93-100
Role of monoamine oxidases to oxidative modification of myocardial proteins in rats with alloxan diabetes
Diabetes mellitus is associated with a high risk of developing coronary heart disease, cardiac autonomic neuropathy, and diabetic cardiomyopathy, all of which involve oxidative stress mediated by insulin deficiency. The contribution of monoamine oxidases (MAOs) to the development of diabetic cardiomyopathy is currently being intensively studied, and enzyme inhibitors are considered promising cardioprotective drugs for diabetes. However, the possible contribution of MAO-A and MAO-B to direct oxidative damage to proteins and lipids in the myocardium during prolonged hyperglycemia remains unclear. The aim of the study was to assess the role of MAOs in the development of oxidative damage to myocardial proteins in alloxan diabetes. Material and Methods. The study was performed on 54 mature Wistar rats of both sexes. Diabetes mellitus was modeled by intraperitoneal administration of alloxan monohydrate at a dose of 163 mg/kg. To assess the contribution of MAOs to the development of oxidative stress, the MAO-B inhibitor selegiline was administered subcutaneously at a dose of 5 mg/kg daily. On the fourteenth day after alloxan administration, biomaterial for research was obtained. Oxidative modification of proteins in myocardial homogenates was determined spectrophotometrically by reaction with 2,4-dinitrophenylhydrazine, levels of lipid peroxidation products ‒ by extraction-spectrophotometric methods, MAO activity ‒ spectrophotometrically. Results and discussions. Within fourteen days of alloxan administration, an increase in glycemia was observed, accompanied by activation of MAO-A and MAO-B, as well as the accumulation of free radical protein and lipid oxidation products in the myocardium. Administration of selegiline to animals receiving alloxan prevented the activation of MAOs and the accumulation of protein oxidative modification products. These results demonstrate the potential for a direct prooxidant effect of MAOs in the myocardium and support the potential of research aimed at developing approaches that utilize drugs that modulate MAO activity in diabetes.
- 30 August 2026
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 46 (4) , 93-100
Open AccessRole of monoamine oxidases to oxidative modification of myocardial proteins in rats with alloxan diabetes
Diabetes mellitus is associated with a high risk of developing coronary heart disease, cardiac autonomic neuropathy, and diabetic cardiomyopathy, all of which involve oxidative stress mediated by insulin deficiency. The contribution of monoamine oxidases (MAOs) to the development of diabetic cardiomyopathy is currently being intensively studied, and enzyme inhibitors are considered promising cardioprotective drugs for diabetes. However, the possible contribution of MAO-A and MAO-B to direct oxidative damage to proteins and lipids in the myocardium during prolonged hyperglycemia remains unclear. The aim of the study was to assess the role of MAOs in the development of oxidative damage to myocardial proteins in alloxan diabetes. Material and Methods. The study was performed on 54 mature Wistar rats of both sexes. Diabetes mellitus was modeled by intraperitoneal administration of alloxan monohydrate at a dose of 163 mg/kg. To assess the contribution of MAOs to the development of oxidative stress, the MAO-B inhibitor selegiline was administered subcutaneously at a dose of 5 mg/kg daily. On the fourteenth day after alloxan administration, biomaterial for research was obtained. Oxidative modification of proteins in myocardial homogenates was determined spectrophotometrically by reaction with 2,4-dinitrophenylhydrazine, levels of lipid peroxidation products ‒ by extraction-spectrophotometric methods, MAO activity ‒ spectrophotometrically. Results and discussions. Within fourteen days of alloxan administration, an increase in glycemia was observed, accompanied by activation of MAO-A and MAO-B, as well as the accumulation of free radical protein and lipid oxidation products in the myocardium. Administration of selegiline to animals receiving alloxan prevented the activation of MAOs and the accumulation of protein oxidative modification products. These results demonstrate the potential for a direct prooxidant effect of MAOs in the myocardium and support the potential of research aimed at developing approaches that utilize drugs that modulate MAO activity in diabetes.
- 3 June 2026
- Published by Alfmed LLC in Medical alphabet
- No. 7
Study of heparan sulfate proteoglycan, a marker of endothelial dysfunction in medical workers(pilotstudy)
Endothelial dysfunction (ED) is a universal developmental mechanism of most diseases of various body systems, characterized by a decrease in vasodilation and the development of proinflammatory and prothrombotic conditions. Impaired vasodilation is primarily associated with a decrease in production and bioavailability of endogenous nitric oxide (NO). One of the methods for ED assessment is measuring the level of markers of its damage in blood serum, such as homocysteine (HCYS), monocyte chemotactic protein‑1 (MCP‑1), proteins of vascular endothelial growth factor (VEGF) family, and many others with low diagnostic effectiveness. In recent years, a number of studies have shown a reliable association between the level of Heparan Sulfate Proteoglycan (hHSPG) and endothelial damage in various acute and chronic diseases. The purpose of the study. To perform a pilot study of hHSPG levels in comparison with other biomarkers of endothelial damage in blood serum and to identify the correlation of their levels with blood flow rates and endothelial function in microcirculatory system and large vessels in healthy medical workers. Material and methods. The study involved healthy male medical workers (n=21). The levels of hHSPG, HCYS, MCP‑1, VEGF‑A in blood serum were measured by enzyme immunoassay. According to the results of the study, two groups were formed – an experimental group (n=6) with a significant increase in hHSPG level and a control group (n=15) with a normal level of this marker. In these groups blood flow and endothelial function were assessed using bulbar conjunctival capillaroscopy, laser Doppler flowmetry (LDF) of the skin and photoplethysmographic examination of upper extremity vessels. The results of the study. In experimental group a high level of hHSPG was detected, exceeding the upper reference range for this marker by more than 2 times to values of 26.6 [24.775; 28.15] ng/ml compared with the control group, where the level of this marker was 4.879 [3.84; 6.944] ng/ml (p=0.001). In addition, there was a tendency in MCP‑1 marker increase in experimental group – 201.96 [91.9; 220.2] pg/ml compared with the control group 104.91 [72.62;127.67] pg/ml (p=0.052). Correlation analysis of hHSPG with markers HCYS, MCP‑1, VEGF‑A showed a strong positive association between hHSPG and MCP‑1 (r s =0.746), as well as between HCYS and VEGF‑A (r s =0.436) and between MCP‑1 and VEGF‑A (r s =0,286). According to the results of blood circulation instrumental study a significant difference in the characteristics of capillary blood flow between the groups was revealed: a decrease in capillary density (10,15 [2.57; 11.60]% in main and 14.90 [10.90; 17.00]% in control (p=0.018)) in bulbar conjunctival microscopy, as well as decrease in capillary bed perfusion (6.80 [5.39; 15.98] in main and 25.02 [18.9; 32.98] in control (p=0.005)) and decreased endothelial function (0.14 [0.02; 0.31] in main and 0.76 [0.55; 1.04] in control (p=0.002)) in LDF. In plethysmographic examination there were no differences in arterial stiffness index (SI) and reflection index (RI). Correlation analysis of laboratory and instrumental ED parameters showed the presence of a moderate inverse relationship between the level of Heparan Sulfate Proteoglycan and endothelial function (Ae) measured by LDF (p=0.024, r s = –0.491). Conclusion. An increase in Heparan Sulfate Proteoglycan is a promising marker of ED at the initial stage of its development in microcirculatory system.
- 3 June 2026
- Published by Alfmed LLC in Medical alphabet
- No. 7
Study of heparan sulfate proteoglycan, a marker of endothelial dysfunction in medical workers(pilotstudy)
Endothelial dysfunction (ED) is a universal developmental mechanism of most diseases of various body systems, characterized by a decrease in vasodilation and the development of proinflammatory and prothrombotic conditions. Impaired vasodilation is primarily associated with a decrease in production and bioavailability of endogenous nitric oxide (NO). One of the methods for ED assessment is measuring the level of markers of its damage in blood serum, such as homocysteine (HCYS), monocyte chemotactic protein‑1 (MCP‑1), proteins of vascular endothelial growth factor (VEGF) family, and many others with low diagnostic effectiveness. In recent years, a number of studies have shown a reliable association between the level of Heparan Sulfate Proteoglycan (hHSPG) and endothelial damage in various acute and chronic diseases. The purpose of the study. To perform a pilot study of hHSPG levels in comparison with other biomarkers of endothelial damage in blood serum and to identify the correlation of their levels with blood flow rates and endothelial function in microcirculatory system and large vessels in healthy medical workers. Material and methods. The study involved healthy male medical workers (n=21). The levels of hHSPG, HCYS, MCP‑1, VEGF‑A in blood serum were measured by enzyme immunoassay. According to the results of the study, two groups were formed – an experimental group (n=6) with a significant increase in hHSPG level and a control group (n=15) with a normal level of this marker. In these groups blood flow and endothelial function were assessed using bulbar conjunctival capillaroscopy, laser Doppler flowmetry (LDF) of the skin and photoplethysmographic examination of upper extremity vessels. The results of the study. In experimental group a high level of hHSPG was detected, exceeding the upper reference range for this marker by more than 2 times to values of 26.6 [24.775; 28.15] ng/ml compared with the control group, where the level of this marker was 4.879 [3.84; 6.944] ng/ml (p=0.001). In addition, there was a tendency in MCP‑1 marker increase in experimental group – 201.96 [91.9; 220.2] pg/ml compared with the control group 104.91 [72.62;127.67] pg/ml (p=0.052). Correlation analysis of hHSPG with markers HCYS, MCP‑1, VEGF‑A showed a strong positive association between hHSPG and MCP‑1 (r s =0.746), as well as between HCYS and VEGF‑A (r s =0.436) and between MCP‑1 and VEGF‑A (r s =0,286). According to the results of blood circulation instrumental study a significant difference in the characteristics of capillary blood flow between the groups was revealed: a decrease in capillary density (10,15 [2.57; 11.60]% in main and 14.90 [10.90; 17.00]% in control (p=0.018)) in bulbar conjunctival microscopy, as well as decrease in capillary bed perfusion (6.80 [5.39; 15.98] in main and 25.02 [18.9; 32.98] in control (p=0.005)) and decreased endothelial function (0.14 [0.02; 0.31] in main and 0.76 [0.55; 1.04] in control (p=0.002)) in LDF. In plethysmographic examination there were no differences in arterial stiffness index (SI) and reflection index (RI). Correlation analysis of laboratory and instrumental ED parameters showed the presence of a moderate inverse relationship between the level of Heparan Sulfate Proteoglycan and endothelial function (Ae) measured by LDF (p=0.024, r s = –0.491). Conclusion. An increase in Heparan Sulfate Proteoglycan is a promising marker of ED at the initial stage of its development in microcirculatory system.
- Open Access
- 10 October 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (8) , 6252
Clinical and serum risk factors for coronary restenosis in patients with coronary artery disease
Aim. To study risk factors for coronary artery restenosis in a retrospective (identification of patients with restenosis) and prospective (biomarker analysis) study.Material and methods. Patients with coronary stenosis were identified within 7 years after primary stenting. In 181 patients (67 — with coronary restenosis, 114 — without coronary restenosis), the clinical, demographic and serum biomarker profiles of patients were studied.Results. The incidence of coronary restenosis was significantly higher in men (82,1% and 69,3%, p=0,047). Propensity score matching was used to balance the groups by sex, and as a result, a higher hereditary predisposition to cardiovascular diseases (p=0,024), sinus rhythm (p=0,020), low serum apolipoprotein A1 (p=0,048) and high alanine aminotransferase (p=0,023) were shown for the restenosis group.Conclusion. Coronary artery restenosis was characterized by male sex, sinus rhythm, hereditary predisposition, increased alanine aminotransferase and decreased apolipoprotein A1.
- 10 October 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (8) , 6252
Open AccessClinical and serum risk factors for coronary restenosis in patients with coronary artery disease
Aim. To study risk factors for coronary artery restenosis in a retrospective (identification of patients with restenosis) and prospective (biomarker analysis) study.Material and methods. Patients with coronary stenosis were identified within 7 years after primary stenting. In 181 patients (67 — with coronary restenosis, 114 — without coronary restenosis), the clinical, demographic and serum biomarker profiles of patients were studied.Results. The incidence of coronary restenosis was significantly higher in men (82,1% and 69,3%, p=0,047). Propensity score matching was used to balance the groups by sex, and as a result, a higher hereditary predisposition to cardiovascular diseases (p=0,024), sinus rhythm (p=0,020), low serum apolipoprotein A1 (p=0,048) and high alanine aminotransferase (p=0,023) were shown for the restenosis group.Conclusion. Coronary artery restenosis was characterized by male sex, sinus rhythm, hereditary predisposition, increased alanine aminotransferase and decreased apolipoprotein A1.
- 30 June 2025
- Published by LLC Science and Innovations in Saratov Medical Journal
- Vol. 6 (2)
Polymorphisms of hemostasis and folate cycle genes as predictors of COVID-19 severity
Objective: to identify the frequency of single nucleotide polymorphisms (SNPs) of hemostasis and folate cycle genes in patients with stable coronary artery disease (CAD) depending on the severity of COVID-19 in the acute period. Materials and methods. Our study included 416 patients with CAD who had COVID-19 more than 12 weeks ago with documented severity course. All patients were distributed among two groups. Group 1 included patients with mild severity (n=203), while Group 2 comprised patients with moderate severity (n=213) of COVID-19. All study subjects were examined for polymorphisms of hemostasis and folate cycle genes. We performed an assessment of the following genetic variants: 20210 G>A of the F2 gene, 1691 G>A of the F5 gene, 807 C>T of the ITGA2 gene, 10976 G>A of the F7 gene, 1298A>C of the MTHFR gene, 66 A>G of the MTRR gene, 2756 A>G of the MTR gene, 677 C>T of the MTHFR gene, 455 G>A of the FGB gene, 103 G>T of the F13A1 gene, 675 5G>4G of the SERPINE1 (PAI-1) gene, and 1565 T>C of the ITGB3 gene. These polymorphisms are likely to contribute to a more severe course of COVID-19 in patients with CAD. Results. Predisposing factors for the development of a more severe course of COVID-19 among patients with CAD may be the presence of heterozygous polymorphism (455 G>A) of the FGB gene and 1565 T>C polymorphism (CC genotype) of the ITGB3 gene. Contrariwise, the 807 C>T polymorphism (CC genotype) of the ITGA2 gene in the analyzed sample was associated with a mild course of COVID-19. Conclusion. SNPs 455 G>A of the FGB gene and 1565 T>C (rs5918) of the ITGB3 gene are potential markers for identifying and predicting a more severe course of COVID-19 in patients with CAD
- 30 June 2025
- Published by LLC Science and Innovations in Saratov Medical Journal
- Vol. 6 (2)
Polymorphisms of hemostasis and folate cycle genes as predictors of COVID-19 severity
Objective: to identify the frequency of single nucleotide polymorphisms (SNPs) of hemostasis and folate cycle genes in patients with stable coronary artery disease (CAD) depending on the severity of COVID-19 in the acute period. Materials and methods. Our study included 416 patients with CAD who had COVID-19 more than 12 weeks ago with documented severity course. All patients were distributed among two groups. Group 1 included patients with mild severity (n=203), while Group 2 comprised patients with moderate severity (n=213) of COVID-19. All study subjects were examined for polymorphisms of hemostasis and folate cycle genes. We performed an assessment of the following genetic variants: 20210 G>A of the F2 gene, 1691 G>A of the F5 gene, 807 C>T of the ITGA2 gene, 10976 G>A of the F7 gene, 1298A>C of the MTHFR gene, 66 A>G of the MTRR gene, 2756 A>G of the MTR gene, 677 C>T of the MTHFR gene, 455 G>A of the FGB gene, 103 G>T of the F13A1 gene, 675 5G>4G of the SERPINE1 (PAI-1) gene, and 1565 T>C of the ITGB3 gene. These polymorphisms are likely to contribute to a more severe course of COVID-19 in patients with CAD. Results. Predisposing factors for the development of a more severe course of COVID-19 among patients with CAD may be the presence of heterozygous polymorphism (455 G>A) of the FGB gene and 1565 T>C polymorphism (CC genotype) of the ITGB3 gene. Contrariwise, the 807 C>T polymorphism (CC genotype) of the ITGA2 gene in the analyzed sample was associated with a mild course of COVID-19. Conclusion. SNPs 455 G>A of the FGB gene and 1565 T>C (rs5918) of the ITGB3 gene are potential markers for identifying and predicting a more severe course of COVID-19 in patients with CAD
- 30 June 2025
- Published by LLC Science and Innovations in Saratov Journal of Medical Scientific Research
- Vol. 21 (2) , 161-167
Polymorphisms of hemostasis and folate cycle genes as predictors of COVID-19 severity
Objective: to reveal the frequency of hemostasis and folate cycle gene polymorphisms in stable coronary heart disease (CHD) patients based on the severity of COVID-19 during the acute phase. Material and methods. During the study, 416 patients with stable CHD who had previously experienced COVID-19 with documented severity were examined for hemostasis and folate cycle gene polymorphisms. The severity of COVID-19 was used to categorize patients into two groups: the first group included patients with mild cases (n=203), while the second group comprised patients with moderate severity (n=213). The evaluation included the following genetic variants: 20210 G>A of the F2 gene, 1691 G>A of the F5 gene, 807 ОТ of the ITGA2 gene, 10976 G>A of the F7 gene, 1298 A>C of the MTHFR gene, 66 A>G of the MTRR gene, 2756 A>G of the MTR gene, 677 ОТ of the MTHFR gene, 455 G>Aof the FGB gene, 103 G>T of the F13A1 gene, 6755G>4G of the SERPINE1 (PAI-1) gene, and 1565 T>C of the ITGB3 gene. These polymorphisms likely contribute to a more severe course of COVID-19 in patients with CHD. Results. The presence of the heterozygous FGB: 455 G>A polymorphism and the ITGB3: 1565 T>C CC genotype may contribute to more severe COVID-19 progression in patients with CHD. Conversely, the CC genotype of the 807 ОТ polymorphism of the ITGA2 gene was associated with protection against more severe forms of the disease in the analyzed sample. Conclusion. Polymorphisms 455 G>Aof the FGB gene and 1565 T>C of the ITGB3 gene can be considered potential markers for detecting and predicting a more severe course of COVID-19 in patients with CHD.
- 30 June 2025
- Published by LLC Science and Innovations in Saratov Journal of Medical Scientific Research
- Vol. 21 (2) , 161-167
Polymorphisms of hemostasis and folate cycle genes as predictors of COVID-19 severity
Objective: to reveal the frequency of hemostasis and folate cycle gene polymorphisms in stable coronary heart disease (CHD) patients based on the severity of COVID-19 during the acute phase. Material and methods. During the study, 416 patients with stable CHD who had previously experienced COVID-19 with documented severity were examined for hemostasis and folate cycle gene polymorphisms. The severity of COVID-19 was used to categorize patients into two groups: the first group included patients with mild cases (n=203), while the second group comprised patients with moderate severity (n=213). The evaluation included the following genetic variants: 20210 G>A of the F2 gene, 1691 G>A of the F5 gene, 807 ОТ of the ITGA2 gene, 10976 G>A of the F7 gene, 1298 A>C of the MTHFR gene, 66 A>G of the MTRR gene, 2756 A>G of the MTR gene, 677 ОТ of the MTHFR gene, 455 G>Aof the FGB gene, 103 G>T of the F13A1 gene, 6755G>4G of the SERPINE1 (PAI-1) gene, and 1565 T>C of the ITGB3 gene. These polymorphisms likely contribute to a more severe course of COVID-19 in patients with CHD. Results. The presence of the heterozygous FGB: 455 G>A polymorphism and the ITGB3: 1565 T>C CC genotype may contribute to more severe COVID-19 progression in patients with CHD. Conversely, the CC genotype of the 807 ОТ polymorphism of the ITGA2 gene was associated with protection against more severe forms of the disease in the analyzed sample. Conclusion. Polymorphisms 455 G>Aof the FGB gene and 1565 T>C of the ITGB3 gene can be considered potential markers for detecting and predicting a more severe course of COVID-19 in patients with CHD.
- 10 April 2025
- Published by Open Systems Publications in Лечащий врач
- No. 4(28)
Сomparative characteristics of serum and cerebrospinal interleukin-6 values in patients with serous and purulent meningitis
Background. In neuroinfections due to bacteremia or viralemia, generalized vasculitis occurs, including cerebral vessels, which causes the development of endothelial dysfunction. This contributes to vascular thrombosis, impaired vascular regulation, and stimulates neuroinflammation by increasing the secretion of proinflammatory cytokines from immune and neuronal cells such as microglia and astrocytes. Microglia activation is thought to play an important role in neuronal cell death through the release of proinflammatory mediators. Interleukins, interferons, tumor necrosis factor alpha, and factors that activate and inhibit macrophage activity play a leading role in the development of the acute phase response. Objective. Comparison of laboratory parameters of the level of leukocytes in the peripheral blood and biochemical markers of inflammation (CRP, ferritin, IL-6 in the blood serum) and the level of IL-6 in the cerebrospinal fluid in patients with meningitis of various etiologies and patients without inflammatory changes in the central nervous system. The study involved 151 patients hospitalized at the State Budgetary Healthcare Institution of the Novosibirsk region "GIKB No. 1" in 2023-2024 with suspected serous or purulent meningitis. In all patients, laboratory parameters of blood and CSF were assessed, according to the results of which the patients were divided into two groups: patients with neuroinfections of various etiologies with pleocytosis in the cerebrospinal fluid of more than 15 and patients without inflammatory changes in the central nervous system. Results. The study revealed an increase in varying degrees of IL-6 in the cerebrospinal fluid in patients with neuroinfections, and a direct correlation was established between the level of pleocytosis and IL-6 values in the cerebrospinal fluid. A statistically significant increase in the concentration of IL-6 in the cerebrospinal fluid in the acute stage of purulent and serous meningitis was also revealed, which indicates the direct production of IL-6 by neuroglial cells that perform the function of macrophages in the central nervous system.
- 10 April 2025
- Published by Open Systems Publications in Лечащий врач
- No. 4(28)
Сomparative characteristics of serum and cerebrospinal interleukin-6 values in patients with serous and purulent meningitis
Background. In neuroinfections due to bacteremia or viralemia, generalized vasculitis occurs, including cerebral vessels, which causes the development of endothelial dysfunction. This contributes to vascular thrombosis, impaired vascular regulation, and stimulates neuroinflammation by increasing the secretion of proinflammatory cytokines from immune and neuronal cells such as microglia and astrocytes. Microglia activation is thought to play an important role in neuronal cell death through the release of proinflammatory mediators. Interleukins, interferons, tumor necrosis factor alpha, and factors that activate and inhibit macrophage activity play a leading role in the development of the acute phase response. Objective. Comparison of laboratory parameters of the level of leukocytes in the peripheral blood and biochemical markers of inflammation (CRP, ferritin, IL-6 in the blood serum) and the level of IL-6 in the cerebrospinal fluid in patients with meningitis of various etiologies and patients without inflammatory changes in the central nervous system. The study involved 151 patients hospitalized at the State Budgetary Healthcare Institution of the Novosibirsk region "GIKB No. 1" in 2023-2024 with suspected serous or purulent meningitis. In all patients, laboratory parameters of blood and CSF were assessed, according to the results of which the patients were divided into two groups: patients with neuroinfections of various etiologies with pleocytosis in the cerebrospinal fluid of more than 15 and patients without inflammatory changes in the central nervous system. Results. The study revealed an increase in varying degrees of IL-6 in the cerebrospinal fluid in patients with neuroinfections, and a direct correlation was established between the level of pleocytosis and IL-6 values in the cerebrospinal fluid. A statistically significant increase in the concentration of IL-6 in the cerebrospinal fluid in the acute stage of purulent and serous meningitis was also revealed, which indicates the direct production of IL-6 by neuroglial cells that perform the function of macrophages in the central nervous system.
- 24 March 2025
- Published by Alfmed LLC in Medical alphabet
- No. 5,p. 17-24
Research of the interrelationships of anemia markers and cytokines in COVID‑19 patients and their clinical informative value
A study was conducted with the participation of 51 male patients with a confirmed diagnosis of COVID‑19. 17 of them were diagnosed with anemia of chronic diseases. The study compared the parameters of hemogram, erythropoietin, iron metabolism (ferritin, transferrin, soluble transferrin receptor, total serum iron binding capacity (SIBC)), as well as interleukin‑1b (IL‑1b), interleukin‑6 (IL‑6), interleukin‑10 (IL‑10), necrosis factor tumors of alpha (TNF-α), interferon-γ (INF-γ) and C-reactive protein (CRP) in patients with anemia of chronic diseases (AСD) on the background of COVID‑19 and a control group of COVID‑19 patients without anemia. As a result of the study of anemia markers, it was found that patients with COVID‑19 and anemia have the highest concentrations of erythropoietin, ferritin, and cytokines (IL‑1b, IL‑6, IL‑10, TNF-alpha), as well as a marker of immune system activity, CRP. In patients with COVID‑19 and AСD, decreased levels of markers reflecting the severity of anemia, such as transferrin and SIBC, as well as INF-γ levels, were detected. According to the results of the correlation analysis, different effects of cytokines on erythropoiesis, hemoglobin synthesis and iron metabolism in the body were revealed. ROC curves were used to analyze the studied markers of anemia in order to differentiate anemia in patients with COVID‑19. The most important markers for diagnosis were indicators of hemoglobin, erythrocytes and SIBC.
- 24 March 2025
- Published by Alfmed LLC in Medical alphabet
- No. 5,p. 17-24
Research of the interrelationships of anemia markers and cytokines in COVID‑19 patients and their clinical informative value
A study was conducted with the participation of 51 male patients with a confirmed diagnosis of COVID‑19. 17 of them were diagnosed with anemia of chronic diseases. The study compared the parameters of hemogram, erythropoietin, iron metabolism (ferritin, transferrin, soluble transferrin receptor, total serum iron binding capacity (SIBC)), as well as interleukin‑1b (IL‑1b), interleukin‑6 (IL‑6), interleukin‑10 (IL‑10), necrosis factor tumors of alpha (TNF-α), interferon-γ (INF-γ) and C-reactive protein (CRP) in patients with anemia of chronic diseases (AСD) on the background of COVID‑19 and a control group of COVID‑19 patients without anemia. As a result of the study of anemia markers, it was found that patients with COVID‑19 and anemia have the highest concentrations of erythropoietin, ferritin, and cytokines (IL‑1b, IL‑6, IL‑10, TNF-alpha), as well as a marker of immune system activity, CRP. In patients with COVID‑19 and AСD, decreased levels of markers reflecting the severity of anemia, such as transferrin and SIBC, as well as INF-γ levels, were detected. According to the results of the correlation analysis, different effects of cytokines on erythropoiesis, hemoglobin synthesis and iron metabolism in the body were revealed. ROC curves were used to analyze the studied markers of anemia in order to differentiate anemia in patients with COVID‑19. The most important markers for diagnosis were indicators of hemoglobin, erythrocytes and SIBC.
- Open Access
- 7 January 2025
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 44 (6) , 197-202
Intestinal monoamine oxidase activity in premature and full-term infants with surgical pathology
Advances in pediatric surgery, intensive care, and anesthesiology have significantly improved the outcomes of surgical treatment of full-term and premature infants with intestinal malformations and necrotizing enterocolitis (NEC). The main challenges in treating children of this complex group today lie in improving diagnostics, choosing treatment tactics, and ensuring the postoperative period. Monoamine oxidase (MAO) is a mitochondrial enzyme that catalyzes oxidative deamination of biogenic and xenobiotic monoamines, including those in intestinal wall cells and tissues. It can be a prognostic and diagnostic marker of the effectiveness and rate of intestinal recovery in the postoperative period, and also serve as a point of application for pharmacological correction. The aim of the study is to determine the activity of intestinal MAO in children of the first year of life with surgical pathology. Material and methods. The study included 24 patients with colon and small intestine pathologies, aged from 1 day to 3 months, who were treated at the Chelyabinsk Regional Children’s Clinical Hospital from October 2022 to May 2024. MAO-A and MAO-B activity was studied by spectrophotometry in intestinal homogenates obtained at the proximal resection margin. Results and discussion. Intestinal samples obtained from patients with diseases accompanied by pronounced inflammatory changes (NEC stage IIIA–IIIB, enterostomy closure after NEC III, intestinal neuronal dysplasia (IND), Hirschsprung’s disease) showed a significant decrease in the activity of the MAO-A isoform. A decrease in MAO-B activity was demonstrated in intestinal wall samples obtained from children with confirmed diagnoses of Hirschsprung’s disease and intestinal neuronal dysplasia, as well as in premature infants with surgical stages of NEC. The highest activity of both enzyme isoforms was found in sigmoid colon samples without pathological changes in patients with anal and rectum atresia.
- 7 January 2025
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 44 (6) , 197-202
Open AccessIntestinal monoamine oxidase activity in premature and full-term infants with surgical pathology
Advances in pediatric surgery, intensive care, and anesthesiology have significantly improved the outcomes of surgical treatment of full-term and premature infants with intestinal malformations and necrotizing enterocolitis (NEC). The main challenges in treating children of this complex group today lie in improving diagnostics, choosing treatment tactics, and ensuring the postoperative period. Monoamine oxidase (MAO) is a mitochondrial enzyme that catalyzes oxidative deamination of biogenic and xenobiotic monoamines, including those in intestinal wall cells and tissues. It can be a prognostic and diagnostic marker of the effectiveness and rate of intestinal recovery in the postoperative period, and also serve as a point of application for pharmacological correction. The aim of the study is to determine the activity of intestinal MAO in children of the first year of life with surgical pathology. Material and methods. The study included 24 patients with colon and small intestine pathologies, aged from 1 day to 3 months, who were treated at the Chelyabinsk Regional Children’s Clinical Hospital from October 2022 to May 2024. MAO-A and MAO-B activity was studied by spectrophotometry in intestinal homogenates obtained at the proximal resection margin. Results and discussion. Intestinal samples obtained from patients with diseases accompanied by pronounced inflammatory changes (NEC stage IIIA–IIIB, enterostomy closure after NEC III, intestinal neuronal dysplasia (IND), Hirschsprung’s disease) showed a significant decrease in the activity of the MAO-A isoform. A decrease in MAO-B activity was demonstrated in intestinal wall samples obtained from children with confirmed diagnoses of Hirschsprung’s disease and intestinal neuronal dysplasia, as well as in premature infants with surgical stages of NEC. The highest activity of both enzyme isoforms was found in sigmoid colon samples without pathological changes in patients with anal and rectum atresia.
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 14 (4)
Diagnostic value of interleukin-6 content in the liver as a marker of secondary inflammatory diseases of the central nervous system in HIV infection
Диагностическое значение содержания интерлейкина 6 в ликворе как маркера вторичных воспалительных заболеваний центральной нервной системы при ВИЧ
- 1 January 2025
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 14 (4)
Open AccessDiagnostic value of interleukin-6 content in the liver as a marker of secondary inflammatory diseases of the central nervous system in HIV infection
Диагностическое значение содержания интерлейкина 6 в ликворе как маркера вторичных воспалительных заболеваний центральной нервной системы при ВИЧ
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (4)
Clinical and laboratory characteristics of tick-borne encephalitis in the Novosibirsk region in 2024 with identification of severity predictors
Introduction. Tick-borne encephalitis (TBE) is a transmissible disease endemic for the Novosibirsk region (NR). The incidence of TBE in the NR is 2,7–5,8 times higher than the Russian average. Despite the fact that the infection is vaccine-preventable, fatal cases are recorded in the NR year after year. Western Siberia is characterized by the circulation of the Siberian subtype of the virus, which affects the central nervous system (CNS) in two-thirds of cases, and in 20–30% of cases, manifestations are focal, with a high risk of mortality or permanent disability. Aim. To analyze cases of TBE in patients of Novosibirsk City Infectious Diseases Clinical Hospital No. 1 (CIDCH) and to establish factors influencing the form and severity of the disease in unvaccinated patients, as well as predictors of the early prognosis of unfavorable severe TBE. Materials and methods. Clinical, epidemiological, and laboratory data were analyzed in 68 patients diagnosed with TBE, hospitalized at CIDCH in 2024. Febrile TBE was recorded in 32% of patients, meningeal TBE – in 41,5%, and focal TBE – in 26,5%. The diagnosis of TBE was verified by detecting immunoglobulin M and G antibodies to the TBE virus using enzyme-linked immunosorbent assay. The results of a complete blood count (CBC), biochemistry for inflammatory markers, and cerebrospinal fluid analysis were estimated in all patients, as well as levels of serum and cerebrospinal fluid of interleukin-6 (IL-6) and ferritin were measured. Results. The average age of patients with the febrile form of TBE was 48 ± 4,2 years. All patients had fever and intoxication. The CBC showed leukocytosis in 27,3% of patients, and absolute lymphopenia in 36,3%. Elevated C-reactive protein (CRP) levels were found in more than half of patients (54,5%). The average age of patients with the meningeal form of TBE was 50,3 ± 5,4 years. The majority of patients (86%) had high fever, while low fever was observed in 4 patients. Severe intoxication and general cerebral syndromes were detected in 93% of cases; the cerebrospinal fluid analysis revealed lymphocytic pleocytosis in 83,3% of patients – from 16 to 648 cells/ml. Leukocytosis was found in 57% of cases, and absolute lymphopenia – in only 14,3% of patients. An increase in CRP values was observed in 13 people, and ferritin – in only 4 people. Among patients with focal forms of TBE, men predominated (77,8%); the average age was 49,7 ± 5,1 years. The meningoencephalo-poliomyelitic form of TBE was diagnosed in 61,1% of patients, while the rest had the meningoencephalitic form of TBE. A fatal outcome was recorded in 3 patients. The CBC revealed leukocytosis in 89% of cases, and absolute lymphopenia in 33%. CRP and ferritin levels were elevated in only half of the patients. Lumbar puncture results revealed pleocytosis – from 100 to 537 cells/μl, neutrophilic in 27,8%. Cerebrospinal fluid IL-6 was significantly elevated – up to 600–800 pg/ml. Conclusion. In unvaccinated patients with TBE, age, time limits for seeking medical care, leukocyte count, lymphopenia, peripheral blood hematocrit, and CRP levels did not correlate with disease severity. Duration and grade of fever, as well as leukocytosis and blood IL-6 levels differed significantly between patients without and with CNS involvement. Pleocytosis levels were significantly higher in patients with focal TBE. Increased cerebrospinal fluid IL-6 levels were observed in severe cases, as well as a direct correlation with pleocytosis levels, which most reliably reflects the severity of CNS involvement in TBE and may predict an unfavorable course of TBE. The identified predominance of males among patients with focal TBE, as well as late seroconversion in a significant proportion of patients, require further study in a larger patient population.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (4)
Clinical and laboratory characteristics of tick-borne encephalitis in the Novosibirsk region in 2024 with identification of severity predictors
Introduction. Tick-borne encephalitis (TBE) is a transmissible disease endemic for the Novosibirsk region (NR). The incidence of TBE in the NR is 2,7–5,8 times higher than the Russian average. Despite the fact that the infection is vaccine-preventable, fatal cases are recorded in the NR year after year. Western Siberia is characterized by the circulation of the Siberian subtype of the virus, which affects the central nervous system (CNS) in two-thirds of cases, and in 20–30% of cases, manifestations are focal, with a high risk of mortality or permanent disability. Aim. To analyze cases of TBE in patients of Novosibirsk City Infectious Diseases Clinical Hospital No. 1 (CIDCH) and to establish factors influencing the form and severity of the disease in unvaccinated patients, as well as predictors of the early prognosis of unfavorable severe TBE. Materials and methods. Clinical, epidemiological, and laboratory data were analyzed in 68 patients diagnosed with TBE, hospitalized at CIDCH in 2024. Febrile TBE was recorded in 32% of patients, meningeal TBE – in 41,5%, and focal TBE – in 26,5%. The diagnosis of TBE was verified by detecting immunoglobulin M and G antibodies to the TBE virus using enzyme-linked immunosorbent assay. The results of a complete blood count (CBC), biochemistry for inflammatory markers, and cerebrospinal fluid analysis were estimated in all patients, as well as levels of serum and cerebrospinal fluid of interleukin-6 (IL-6) and ferritin were measured. Results. The average age of patients with the febrile form of TBE was 48 ± 4,2 years. All patients had fever and intoxication. The CBC showed leukocytosis in 27,3% of patients, and absolute lymphopenia in 36,3%. Elevated C-reactive protein (CRP) levels were found in more than half of patients (54,5%). The average age of patients with the meningeal form of TBE was 50,3 ± 5,4 years. The majority of patients (86%) had high fever, while low fever was observed in 4 patients. Severe intoxication and general cerebral syndromes were detected in 93% of cases; the cerebrospinal fluid analysis revealed lymphocytic pleocytosis in 83,3% of patients – from 16 to 648 cells/ml. Leukocytosis was found in 57% of cases, and absolute lymphopenia – in only 14,3% of patients. An increase in CRP values was observed in 13 people, and ferritin – in only 4 people. Among patients with focal forms of TBE, men predominated (77,8%); the average age was 49,7 ± 5,1 years. The meningoencephalo-poliomyelitic form of TBE was diagnosed in 61,1% of patients, while the rest had the meningoencephalitic form of TBE. A fatal outcome was recorded in 3 patients. The CBC revealed leukocytosis in 89% of cases, and absolute lymphopenia in 33%. CRP and ferritin levels were elevated in only half of the patients. Lumbar puncture results revealed pleocytosis – from 100 to 537 cells/μl, neutrophilic in 27,8%. Cerebrospinal fluid IL-6 was significantly elevated – up to 600–800 pg/ml. Conclusion. In unvaccinated patients with TBE, age, time limits for seeking medical care, leukocyte count, lymphopenia, peripheral blood hematocrit, and CRP levels did not correlate with disease severity. Duration and grade of fever, as well as leukocytosis and blood IL-6 levels differed significantly between patients without and with CNS involvement. Pleocytosis levels were significantly higher in patients with focal TBE. Increased cerebrospinal fluid IL-6 levels were observed in severe cases, as well as a direct correlation with pleocytosis levels, which most reliably reflects the severity of CNS involvement in TBE and may predict an unfavorable course of TBE. The identified predominance of males among patients with focal TBE, as well as late seroconversion in a significant proportion of patients, require further study in a larger patient population.